Novel germinal center kinase proteins, compositions and methods of use
AssigneeRigel Pharmaceuticals, Inc.
InventorsYing Luo, C. Alan Fu, Mary Shen
Life of this patent
Estimating the term…
Loading patent…
AssigneeRigel Pharmaceuticals, Inc.
InventorsYing Luo, C. Alan Fu, Mary Shen
Estimating the term…
The present invention provides compositions and methods for modulating cell proliferation, survival, morphology, and migration. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating proliferation, survival, morphology and migration in mammalian cells are provided. Compositions and methods for the treatment of disorders related to cell proliferation, survival, morphology and migration are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating proliferation, survival, morphology and migration in mammalian cells.
A recombinant nucleic acid, capable of hybridizing to a nucleic acid comprising a nucleic acid sequence selected from the group consisting of the nucleic acid sequences set forth in SEQ ID NOs:
A recombinant nucleic acid, comprising a nucleic acid sequence having at least about 90% identity to a nucleic acid sequence selected from the group consisting of the nucleic acid sequences set forth in SEQ ID NOs:
A recombinant nucleic acid according to claim I or 2, wherein said nucleic acid comprises a nucleic acid sequence selected from the group consisting of the nucleic acid sequences set forth in SEQ ID NOs:
A recombinant polypeptide, comprising an amino acid sequence having at least about 95% identity to an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs:
A method for screening for a candidate bioactive agent capable of modulating phosphorylation of JNK, comprising
A method for screening for a candidate bioactive agent capable of modulating mammalian ERK phosphorylation, comprising:
A method for screening for a candidate bioactive agent capable of modulating mammalian JNK activity, comprising:
A method for screening for a candidate bioactive agent capable of modulating mammalian ERK activity, comprising:
A method for screening for a candidate bioactive agent capable of modulating proliferation in a mammalian cell, comprising:
A method for screening for a candidate bioactive agent capable of modulating growth factor induced-ERK activation in a mammalian cell, comprising:
A method for diagnosing a mammalian cell proliferation disorder, comprising sequencing at least a portion of at least one MINK3 gene encoding a gene transcript comprising a nucleic acid sequence selected from the group consisting of the nucleic acid sequences set forth in SEQ ID NOs:
A medicament for the treatment of a mammalian cell proliferation disorder, comprising a MINK3 antisense nucleic acid comprising a nucleic acid sequence complementary the nucleic acid sequence set forth by nucleotides 2804-3187 in SEQ ID NO:
A method for screening for a candidate agent capable of modulating cell survival, comprising:
Dependencies are inferred from the claim text.